
News|Articles|January 1, 2002
Real-world study finds "unequivocal"lack of difference among SSRIs
The selective serotonin reuptake inhibitors (SSRIs) fluoxetine, sertraline,and paroxetine are equally effective and tolerated in depressed patientsacross a broad range of outcome measures. So finds an open-label, randomizedstudy in 573 patients treated for depression for 9 months in a primary caresetting.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Judi Health, Employers Health team up to launch new PBM solution
2
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
3
Brandon Kessler on pharmacy pricing under CAA 2026 | PBMI 2026
4
Brandon Kessler on advice to employers about meeting their fiduciary responsibility | PBMI 2026
5























